REFERENCES
- Anderson S, Meyer TW, Rennke HG, Brenner BM, Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 1985; 76: 612–619.
- Anderson S, Rennke HG, Brenner BM, Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat, J Clin Invest 1986; 77: 1993–2000.
- Björck S, Nyberg G, Mulec H, Granerus G, Herlitz H, Aurell M, Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy, Br Med J 1986; 293: 471–474.
- Bomanji J, Flatman WD, Horne T, Quantitation of iodine-123 MIBG uptake by normal adrenal medulla in hypertensive patients, J Nucl Med 1987; 28: 319–324.
- Brenner BM, Meyer TW, Hostetter TH, Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive sclerosis in aging, renal ablation and intrinsic renal disease, N Engl J Med 1982; 307: 652–660.
- Brôchner-Mortensen J, A simple method for the determination of glomerular filtration rate, Scand J Clin Lab Invest 1972; 30: 271–274.
- Brôchner-Mortensen J, Freund LG, Reliability of routine clearance methods for assessment of glomerular filtration rate in advanced renal insufficiency, Scand J Clin Lab Invest 1981; 41: 91–97.
- Churg J, Cotran RS, Sinniah R, Sakaguchi H, Sobin L, Renal disease, Classification and atlas of tubulointerstitial diseases, Tokyo: Igaku-Shoin, 1985.
- Hommel E, Parving H-H, Mathiesen E, Edsberg B, Nielsen MD, Giese J, Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy, Br Med J 1986; 293: 467–470.
- Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM, Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation, Am J Physiol 1981; 241: F85–F93.
- Hostetter TH, Rennke HG, Brenner BM, The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies, Am J Med 1982; 72: 375–380.
- Hricik DE, Browning PJ, Koppelmann R, Goorno WE, Madias NE, Dzan VJ, Captopril-induced functional renal insufficiency in patients with bilateral renal artery-stenosis or renal-artery stenosis in a solitary kidney, N Engl J Med 1983; 308: 373–376.
- Meyer TW, Anderson S, Rennke HG, Brenner BM, Converting enzyme inhibitor therapy limits progressive glomerular injury in rats with renal insufficiency, Am J Med 1985; 79 (3C): 31–36.
- Meyer TW, Anderson S, Rennke HG, Brenner BM, Control of glomerular hypertension retards progression of established glomerular injury in rats with renal ablation, Kidney Int 1985; 27: 247a.
- Mimran A, Brunner HR, Turini GA, Waeber B, Brunner D, Effect of captopril on renal vascular tone in patients with essential hypertension, Clin Sc 1979; 59: 421–423.
- Mitch WE, Walser M, Buffington GA, Lemann J, A simple method of estimating progression of chronic renal failure, Lancet 1976; 2: 1326–1328.
- Navis G, de Jong PE, Donker AJM, van der Hem GK, de Zeeuw D, Effects of enalaprillic acid on sodium excretion and renal hemodynamics in essential hypertension, J Clin Hypertens 1985; 1: 228–238.
- Reams GP, Bauer JH, Effects of enalapril in subjects with hypertension associated with moderate to severe renal dysfunction, Arch Intern Med 1986; 146: 2145–2148.
- Wenting GJ, Tan-Tjiong HL, Derkx FHM, de Bruyn JHB, Man in't Veld AJ, Schalekamp MADH, Split renal function in unilateral renal artery stenosis, Br Med J 1984; 288: 886–890.
- Zatz R, Dunn R, Meyer TW, Anderson S, Rennke HG, Brenner BM, Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension, J Clin Invest 1986; 77: 1925–1930.